International Patent: CXCL12-TARGETING MONOCLONAL NEUTRALIZING ANTIBODY AND USE THEREOF IN TREATMENT OF CXCL12 AXIS-RELATED DISEASE

GENEVA, Sept. 24 -- THE FOURTH MILITARY MEDICAL UNIVERSITY filed a patent application (CN2026/083889) for “CXCL12-TARGETING MONOCLONAL NEUTRALIZING ANTIBODY AND USE THEREOF IN TREATMENT OF CXCL12 AXIS-RELATED DISEASE”. With publication no. WO/2026/194860, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/24

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....